[ExI] Alzheimer’s

Keith Henson hkeithhenson at gmail.com
Mon Sep 5 06:04:12 UTC 2016

In its highest dose, the drug was recently shown to annihilate amyloid
plaques in the brains of a subset of the study’s 165 participants.
It could cost up to $2.5 billion dollars to test it widely, but the
investment might be worth the price tag: if it works, aducanumab could
treat people for Alzheimer’s before they even show symptoms.

More information about the extropy-chat mailing list